基本信息
views: 423
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I have been actively involved in the development and validation of novel imaging probes and have also pioeered the development of radionuclide therapy in Australia, especially the use of Sr-89, I-131 MIBG, I-131 rituxan, In-111 octreotide, Lu-177 octreotate and Lu177 PSMA. The treatment of neuroendocrine tumours and neuroblastoma are of particular interest to me. My clinical activities are underpinned by a strong interest in fundamental and translational research. I am passionate about advocacy on behalf of patients with rare cancers who are discriminated against by a system that values large industry-funded studies in common cancers above personalised medicine based on unique characterisation of the patient and their disease.
Specialties: Molecular Imaging and Radionuclide Therapy
Specialties: Molecular Imaging and Radionuclide Therapy
Research Interests
Papers共 953 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF NEUROENDOCRINOLOGYno. 1 (2024)
PET CLINICSno. 2 (2024): 291-306
European journal of nuclear medicine and molecular imagingno. 8 (2024): 2428-2441
Aidan Flynn,Andrew D Pattison,Shiva Balachander,Emma Boehm,Blake Bowen,Trisha Dwight,Fernando Rosello, Oliver Hofmann,Luciano Martelotto, Maia Zethoven,Lawrence S Kirschner,Tobias Else,
Research square (2024)
Rachael Fox, Sarah Chang, Lauren Hicks,Samantha Mooney,Peter A.W. Rogers,Rodney J. Hicks,Kate Tyson,Sarah J. Holdsworth-Carson
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024): 258-265
Biomedical physics & engineering expressno. 2 (2024)
Journal of Neuroendocrinologyno. 1 (2024)
Journal of Neuroendocrinology (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn